Healthy Skepticism Library item: 6684

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Bayer claims that “nifedipine significantly reduces the incidence of cardiovascular events”
MaLAM Australian News 1996 Jul-Aug; 4:(7-8):2

Abstract:

Bayer’s new promotion of Adalat (nifedipine) is seriously misleading and MaLAM has sent in a complaint to the Australian Pharmaceutical Manufacturers Association.

Keywords:
*analysis/Australia/developed countries/Bayer/Adalat/nifedipine/quality of information/ Australian Pharmaceutical Manufacturers Association/ Code of Conduct (Aus)/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION